LBI-HTA - Publications - Search - Horizon Scanning in Oncology 34th Prioritisation – 1st quarter 2018

Grössmann, N. and Wolf, S. (2018): Horizon Scanning in Oncology 34th Prioritisation – 1st quarter 2018. HSO: 34th Prioritisation.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
514Kb
Abstract

For the 34 prioritisation (January 2018), 15 drugs were filtered out of 405 identified and were sent to prioritisation. Of these, seven drugs were ranked as "highly relevant" by the expert panel, seven as "relevant" and one as "not relevant". For "highly relevant" drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.

Item Type:DSD: Horizon Scanning in Oncology
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
QZ Pathology > QZ 200-380 Neoplasms.Cysts
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
Language:English
Series Name:HSO: 34th Prioritisation
Deposited on:15 Jan 2018 18:20
Last Modified:15 Jan 2018 18:20

Repository Staff Only: item control page